Purchase Order 75N91024P00495
Award Date
5/24/24
Potential Completion Date
6/6/24
Potential Value
$15K
Federal Agency
National Cancer Institute
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
DA01 - It And Telecom - Business Application/Application Development Support Services (Labor)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,896.00 firm fixed-price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB services. The contract has an ultimate completion date of November 30, 2024 and was awarded on December 1, 2023. This award does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided various...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency under the Department of Health and Human Services, to Qiagen, LLC for the provision of HGMD (Human Gene Mutation Database) download and research use services. The contract has a period of performance from December 25, 2024 to December 24, 2025 with a ceiling value of $24,169.00. The contract is not set aside for any specific business type. Qiagen, LLC is a division of the...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract has a total ceiling value of $19,008.00 and a period of performance ending on March 30, 2026. The contract does not have a set-aside designation. Qiagen, LLC will provide a range of products and services to support the NIH's biomedical research, public health, and healthcare programs, including...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC for a maintenance agreement valued at $13,967.00. The contract has an ultimate completion date of August 31, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. Qiagen has provided a range of...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $22,324.00 contract is for the provision of various products and services to support the NIH's biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems,...
This firm fixed-price purchase order contract was awarded by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $80,047.85 contract is for the delivery of Qiagen's sample and assay technologies, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and related bioinformatics software. Qiagen has provided these types of...
This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC, a division of Qiagen N.V. The contract, valued at $32,995.00, is to provide Ingenuity Variant Analysis software and services in support of the agency's biomedical research programs. Qiagen, a provider of sample and assay technologies, has a history of providing products and...